Salesforce enters its Q1 FY2027 earnings on May 27 with a genuinely split message: short sellers have nearly doubled their positions since early April, while options traders just flipped to their most bullish reading of the past year.
The short-interest build is the dominant data story. Short interest has climbed to roughly 8.6% of the free float — a level that was sitting closer to 5% at the start of April. The jump is sharp: a 73% increase over the past month in raw share terms. Yet the direction eased this week. Shorts trimmed about 4% from their positions between May 11 and May 14, pulling back from a recent peak near 9.1% of float. Days to cover is running at 6.6 days on FINRA's official count, which puts meaningful cover risk on the table if sentiment shifts. Borrow conditions are not the constraint here — cost to borrow is a modest 0.47%, barely changed over the past month, and borrow availability remains comfortable. The short build looks more like a deliberate pre-earnings bearish thesis than a squeeze-prone structure.
Options tell the opposite story, and the contrast is stark. The put/call ratio dropped to 0.74 on May 15 — more than three standard deviations below the 20-day average of 0.82. That is the lowest reading of the past year. For most of the preceding five weeks, the PCR had been running steadily above 0.80, reflecting cautious positioning. The single-session shift on May 15 suggests a rotation into calls as the stock rebounded 3.5% on the day. Whether this reflects conviction ahead of the May 27 print or simply cover-related call buying from shorts trimming remains the open question.
The analyst community holds a buy consensus, but the tone of recent activity leans cautious on valuation. Citigroup's Tyler Radke, reiterated Neutral just this week, cutting his price target from $200 to $188 — the only change inside the past 14 days. Elsewhere, the broader pattern over the past two months has been target cuts with ratings held: JP Morgan trimmed to $320 from $365, Piper Sandler lowered to $215 from $250, and Macquarie cut to $200 from $265, all while keeping their recommendations unchanged. The mean Street target is $268, which implies roughly 54% upside from the $173.51 close — a gap that reflects how far the stock has fallen year-to-date (down 37%) more than fresh optimism. The P/E multiple has compressed about seven points over the past week to 12.1x, while P/B slipped below 2.5x. Bulls point to the Agentforce platform and CRM's Customer 360 positioning in an AI-driven enterprise cycle; bears flag accuracy concerns in the AI layer and execution risk against a backdrop of rising costs and intensifying competition.
On the institutional side, founder and CEO Marc Benioff sold roughly $4.3 million worth of shares on April 22 at $189.80 — well above the current price — alongside co-founder and CTO G. Parker Harris and Co-President Srinivas Tallapragada, who sold similar-sized tranches on the same day. Net insider selling over the past 90 days totals approximately $12.2 million. These look like pre-planned disposals rather than a single directional signal, but the collective timing — ahead of a 9% decline in the share price since those sales — means the register will be scrutinised post-earnings.
Salesforce's last print, in February, delivered a 7.6% one-day gain with the rally extending to 4.1% by end of week. The stock arrives at this next report in materially different circumstances — down sharply from those February levels, with a much larger short base and a peer group that spent the week mixed: NOW gained 4.3% on the week while HUBS was roughly flat, and WDAY and ADBE each gave back around 2%. The question heading into May 27 is whether the Agentforce narrative and any guidance upgrade can reverse a short position that has built with unusual speed — or whether the current options flip to bullishness turns out to be premature.
See the live data behind this article on ORTEX.
Open CRM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
